Stocklytics Platform
Asset logo for symbol DVA
DaVita
DVA65
$155.06arrow_drop_up1.18%$1.81
S&P500
Asset logo for symbol DVA
DVA65

$155.06

arrow_drop_up1.18%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

DaVita (DVA) Stocklytics Forecast

DaVita Inc. (DVA) is a leading provider of kidney care services, operating a network of dialysis centers across the United States. The company has been growing steadily over the years, benefiting from an aging population and increasing prevalence of diabetes and hypertension, which are the leading causes of kidney disease. Despite the challenges posed by the COVID-19 pandemic, DaVita has shown resilience and has adapted its operations to ensure the safety of its patients and staff. As the healthcare industry continues to evolve, DaVita is well-positioned to capitalize on the growing demand for kidney care services.
In terms of stock price prediction, it is important to consider various factors that can influence DaVita's future performance. One key factor is the company's financials. DaVita has a strong balance sheet with solid revenues and cash flows. This provides a stable foundation for the company's growth and expansion plans. Additionally, DaVita has been investing in technology and innovation, which can drive efficiency and improve patient outcomes. These factors contribute to a positive outlook for the company and its stock price.
add DaVita  to watchlist

Keep an eye on DaVita

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for DaVita (DVA) stock?

Analysts have set a target price of $113.17 for DaVita (DVA), based on forecasts from 29 analysts. The predicted price range extends from a high of $150 to a low of $74. This represents a potential increase of up to -3.26% and a decrease of -52.28% from the current price of $155.06. These forecasts are as of 2021 Aug 12.
help

What are the analyst ratings for DaVita (DVA) stock?

The analyst ratings for DaVita (DVA) are distributed as follows: 2 analysts recommend buying, 5 have a neutral stance, and 2 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering DaVita .
help

What is the AI price prediction for DaVita (DVA) stock?

At present, there is no AI or machine-learning-based price prediction available for DaVita (DVA) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level